Abstract
In 1969 I proposed a mechanism of biological Cyclophosphamide (CYM) activation ( 18) which is shown by figure 1. This pathway was concluded from circumstantial evidence that 4-carboxy-CYM is the main CYM metabolite and the C-4 atom of the molecule ring is the preferential site of biological oxidation. I assumed that one of the metabolites should account for the tumour specific activity of the drug. This we could rule out concerning 4-carboxyCYM although this compound has been identified as the main metabolite by Struck and co-workers in addition to 4-keto-CYM, a non toxic minor metabolite (27).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alarcon, R.A. and Meienhofer, J. (1971). Nature, New Biology, 233, 250–252.
Alarcon, R.A., Meienhofer, J. and Atherton, E. (1972). Cancer Research, 32, 2519–2523.
Alarcon, R.A. Symposium on Metabolism and Mechanism of Action of Cyclophosphamide, London July 10th-12th, 1975. (In press)
Ardenne, M. von, Reitnauer, P.G. and Rohde, K. (1971). Arch. Geschwulstforsch, 38, 15–26.
Bakke, J.E., Feil, V. J., Fjeilstul, C.E. and Thacker, E.J. (1972). J.Agr.Food Chem., 20, 384.
Benckhuysen, C., Van Der Steen, J. and Spanjersberg, E.J. Symposium on Metabolism and Mechanism of Action of Cyclophosphamide, London, July 10th-12th 1975 (In press).
Brock, N. Symposium on Metabolism and Mechanism of Action of Cyclophosphamide, London, July 10th-12th 1975 (In press)
Brock, N. (1972). Czechoslowak Medical Press, Vol. II, Avicenum, Prague, p. 749–756.
Connors, T.A., Cox, P.J., Farmer, P.B., Foster, A.B., Jarman, M. and Macleod, J.K. ( 1974). Biomedical Mass Spectrometry, 1, 130–136.
Connors, T.A., Farmer, P.B., Foster, A.B. and Jarman, M. (1974). Biochem. Pharmacol., 23, 115–129.
Cox, P.J., Farmer, P.B., Foster, A.B., Gilby, E.D. and Jarman, M. Symposium on Metabolism and Mechanism of Action of Cyclophosphamide. London, July 10th-12th, 1975 (In press).
Druckrey, H. (1970). J. Kanser (Ankara), 1, 131–149.
Hill, D.L., Laster, W.R., Jr. and Struck, R.F. (1972). Cancer Research, 32, 658–665.
Hill, D.L., Laster, W.R., Jr., Kirk, M.C., El Dreer, S. and Struck, R.F. (1973). Cancer Research, 33, 1016–1022.
Hohorst, H.J. ( 1973). Paper held at the second meeting of the European Association for Cancer Research, Heidleberg, October 2–5th.
Kaye, C.M. (1973). Biochem. J., 134, 1093–1101.
Kaye, C.M. and Joung, (1974). Biochem. Soc. Trans. 2, 308.
Norpoth, K. (1969). Habilitationsschrift, Munster.
Norpoth, K., Addicks, H.W. and Witting, U. (1973). Arzneim. Forsch. (Drug Res.), 23, 1529–1535.
Norpoth, K., Wust, G. and Witting, U. (1972). Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 78, 1561–1564.
Norpoth, K. Symposium on Metabolism and Mechanism of Action of Cyclophosphamide, London, July 10–12th, 1975.
Norpoth, K., Witting, U. and Rauen, H.M. (1974). Arzneim. Forsch. (Drug Res.), 24, 86–89.
Norpoth, K. and Witting, U. Unpublished results.
Peter, G. and Hohorst, H.J. Symposium on Metabolism and Mechanism of Action of Cyclophosphamide. London, July 10–12th, 1975. ( In press).
Sawicki, E., Bender, D.F., Hanser, T.R., Wilson, R.M. and Meeker, J.E. (1963). Anal. Chem., 35, 1479–1486.
Sawicki, E. and Sawicki, C.R. (1969). Ann. N.Y. Acad. Sci., 163, 895–920.
Struck, R.F., Kirk, M.C, Mellet, L.B., El Dareer, S. and Hill, D.L. (1971). Molecular Pharmacology, 7, 519–529.
Struck, R.F. (1974). Cancer Research, 34, 2933–2935.
Takamizawa, A., Matsumoto, S., Iwata, T., Katagiri, K., Tochino, Y. and Yamaguchi, K. (1973). J. Am. Chem. Soc, 95, 985–986.
Takamizawa, A., Matsumoto, S. and Iwata, T. (1974). Tetrahedron Letters, 6, 517–520.
Takamizawa, A., Iwata, T., Matsumoto, S., Yamagucki, K., Shiratory, O., Harada, M. and Tochino, Y. Symposium on Metabolism and Mechanism of Action of Cyclophosphamide. London, July 10–12th, 1975. (In press).
Whitehouse, M.W., Beck, F.J. and Kacena, A. (1974). Agents and Action, 4, 1.
Yllner, S. (1971). Acta pharmacol. et toxicol., 30, 69–80.
Yllner, S. (1971). Acta pharmacol. et toxicol., 30, 257–265.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Norpoth, K. (1976). Analogues and Metabolites of Cyclophosphamide. In: Hellmann, K., Connors, T.A. (eds) Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4349-3_16
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4349-3_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4351-6
Online ISBN: 978-1-4613-4349-3
eBook Packages: Springer Book Archive